These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36033536)

  • 1. Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients.
    Chen D; Dou C; Liu H; Xu B; Hu B; Kuang L; Yao J; Zhao Y; Yu S; Li Y; Wang F; Guo M
    Front Oncol; 2022; 12():929233. PubMed ID: 36033536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
    Xia P; Li Q; Wu G; Huang Y
    Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma.
    Xia P; Huang Y; Chen G
    Front Oncol; 2022; 12():940220. PubMed ID: 36033510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
    Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L
    Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
    Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
    Front Immunol; 2022; 13():916800. PubMed ID: 35860239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
    Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
    Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
    Xiang Z; Chen X; Lv Q; Peng X
    Front Genet; 2021; 12():697819. PubMed ID: 34408772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
    Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
    Front Genet; 2022; 13():966896. PubMed ID: 36186456
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer.
    Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X
    Front Genet; 2022; 13():984696. PubMed ID: 36092933
    [No Abstract]   [Full Text] [Related]  

  • 10. Comprehensive Analysis of Necroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients With Colon Cancer.
    Liu L; Huang L; Chen W; Zhang G; Li Y; Wu Y; Xiong J; Jie Z
    Front Mol Biosci; 2022; 9():811269. PubMed ID: 35237659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma.
    Zhang R; Li Q; Yu X; Hou Y; Yan L; Gao Y; Ji L; Zhang X; Fang M; Huang L; Yu Z; Gao Y; Li M
    Heliyon; 2023 Nov; 9(11):e22083. PubMed ID: 38034714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma.
    Jiang F; Zhan Z; Yang Y; Liu G; Liu S; Gu J; Chen Z; Wang Z; Chen G
    J Oncol; 2022; 2022():5681206. PubMed ID: 36065303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma.
    Peng Y; Wu G; Qiu X; Luo Y; Zou Y; Wei X; Li A
    Front Genet; 2022; 13():916024. PubMed ID: 36110223
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of Long Non-coding RNAs Associated With Microenvironment on Survival for Bladder Cancer Patients.
    Lin G; Guo B; Wei Y; Lan T; Wen S; Li G
    Front Genet; 2020; 11():567200. PubMed ID: 33281872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
    Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer.
    Duan X; Hou R; Huang Y; Wang C; Liu L; Du H; Shi J
    Transl Oncol; 2024 Aug; 46():101983. PubMed ID: 38797018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.